Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Feld

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Rheumatology|November 17, 2014
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritisMichael Zisapel, Devy Zisman, Noa Madar-Balakirski, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
European Journal of Clinical Investigation|June 2, 2020
The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritisShmuel Tiosano, Yarden Yavne, Abdulla Watad, et al.
The Israel Medical Association Journal : IMAJ|November 25, 2020
A Study of the Efficacy and Safety of Subcutaneous Injections of Tocilizumab in Adults with Rheumatoid ArthritisPnina Langevitz, Merav Lidar, Itzhak Rosner, et al.
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Annals of the Rheumatic Diseases|June 15, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Rheumatology|November 17, 2014
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritisMichael Zisapel, Devy Zisman, Noa Madar-Balakirski, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
The Journal of Rheumatology|February 9, 2018
Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter StudyLihi Eder, Paula Harvey, Vinod Chandran, et al.
European Journal of Clinical Investigation|June 2, 2020
The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritisShmuel Tiosano, Yarden Yavne, Abdulla Watad, et al.
The Israel Medical Association Journal : IMAJ|November 25, 2020
A Study of the Efficacy and Safety of Subcutaneous Injections of Tocilizumab in Adults with Rheumatoid ArthritisPnina Langevitz, Merav Lidar, Itzhak Rosner, et al.
The Journal of Rheumatology|November 1, 2023
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent ControlsTali Eviatar, Victoria Furer, Ari Polachek, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Vaccines|June 24, 2022
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with RituximabVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Annals of the Rheumatic Diseases|June 15, 2021
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre studyVictoria Furer, Tali Eviatar, Devy Zisman, et al.
Frontiers in Immunology|March 30, 2023
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinationsFadi Kharouf, Tali Eviatar, Maya Braun, et al.
Pageof 4